Skip to contentW
Whitehawk Therapeutics, Inc.
W
WHWKWhitehawk Therapeutics, Inc. WHWK Q2 2017 · Whitehawk Therapeutics, Inc. · ThalerReleased Aug 10, 2017, after the close
10-Q filed Aug 10, 2017, 41 days after period end · 0001564590-17-017234
Q2 2017 · 10-Q
Revenue—
Net Income-$5.52M-$5.52MN/M vs Q2 2016N/M vs Q1 2017 EPS Diluted
No earnings release is on file for this quarter. Its figures came with the 10-Q.
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Whitehawk Therapeutics, Inc. · CIK 1422142 · Engraved from SEC EDGAR
-$0.21-$0.21
N/M vs Q1 2017
Operating Income-$5,583,862N/M Operating Cash Flowderived-$6,322,934N/M Free Cash Flowderived-$6,327,273N/M Filing lag
ended Jun 30, 2017 · filed Aug 10, 2017 · 41 d after period end